A recent meta-analysis found that Ki67 difference after neoadjuvant chemotherapy in breast cancer patients was associated with worse DFS and OS11, while there was limited data about the prognostic value of Ki67 difference between OEB and CNB. This evidence concerns the gene MKI67 and breast cancer.